Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-28 Sale |
2020-12-30 4:00 pm |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
84,176 | $3.91 | $329,128 | 531,206 (Indirect Direct) |
View |
| 2020-11-04 Purchase |
2020-11-06 6:33 pm |
GLYCOMIMETICS INC | GLYC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,266,737 | $2.6 | $3,293,516 | 630,453 (Direct) |
View |
| 2020-10-30 Purchase |
2020-11-03 4:44 pm |
GLYCOMIMETICS INC | GLYC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
932,612 | $2.75 | $2,564,683 | 544,363 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-08-10 4:16 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer |
0 | $0 | 1,647,600 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:58 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director |
15,750 | $0 | 53,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:55 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:54 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:51 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
15,750 | $0 | 27,247 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:49 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Koenig Scott Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:47 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director |
15,750 | $0 | 15,750 (Direct) |
View |
Ownership |
2021-03-08 4:14 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Feldman Eric Jay Chief Medical Officer |
0 | $0 | 210,498 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:07 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Girard Armand SVP, Chief Business Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:06 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
103,500 | $0 | 108,760 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:05 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Thackray Helen M. SVP Clinical Development, CMO |
103,500 | $0 | 252,115 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:03 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Magnani John L. SVP of Research, CSO |
103,500 | $0 | 398,105 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:00 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
288,750 | $0 | 819,956 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:00 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
130,821 | $1.12 | 531,206 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:00 pm |
N/A 2021-01-04 |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
130,821 | $0 | 531,206 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:00 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
5,260 | $1.12 | 5,260 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:00 pm |
N/A 2021-01-04 |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
5,260 | $0 | 5,260 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:33 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:32 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:31 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | Koenig Scott Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:29 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:28 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:27 pm |
N/A 2030-05-21 |
GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director |
21,000 | $0 | 21,000 (Direct) |
View |